The effect of omega-3 fatty acids on depressive symptoms and inflammatory markers in maintenance hemodialysis patients: a randomized, placebo-controlled clinical trial

EPA but Not DHA Appears To Be Responsible for the Efficacy of Omega-3 Long Chain Polyunsaturated Fatty Acid Supplementation in Depression: Evidence from a Meta-Analysis of Randomized Controlled Trials

(2013) Julian G Martins   JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION

Fish oil as a management component for mood disorders – an evolving signal

(2012) Bronwyn Hegarty et al.   CURRENT OPINION IN PSYCHIATRY

Eicosapentaenoic acid appears to be the key omega-3 fatty acid component associated with efficacy in major depressive disorder: a critique of Bloch and Hannestad and updated meta-analysis

(2012) J G Martins et al.   MOLECULAR PSYCHIATRY

Red blood cell fatty acids are associated with depression in a case-control study of adolescents

(2012) J.V. Pottala et al.   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS

Dietary Omega-3 Fatty Acid, Ratio of Omega-6 to Omega-3 Intake, Inflammation, and Survival in Long-term Hemodialysis Patients

(2011) Nazanin Noori et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial

(2011) Natalie Sinn et al.   BRITISH JOURNAL OF NUTRITION

Could depression be a new branch of MIA syndrome?

(2011) S. Simic Ogrizovic et al.   CLINICAL NEPHROLOGY

Emotional symptoms, quality of life and cytokine profile in hemodialysis patients

(2011) V. Montinaro et al.   CLINICAL NEPHROLOGY

The effect of low-dose omega 3 fatty acids on the treatment of mild to moderate depression in the elderly: a double-blind, randomized, placebo-controlled study

(2011) Yaser Tajalizadekhoob et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Associations of polyunsaturated fatty acids with residual depression or anxiety in older people with major depression

(2011) Ayesha Jadoon et al.   JOURNAL OF AFFECTIVE DISORDERS

Meta-Analysis of the Effects of Eicosapentaenoic Acid (EPA) in Clinical Trials in Depression

(2011) M. Elizabeth Sublette et al.   JOURNAL OF CLINICAL PSYCHIATRY

Omega-3 Fatty Acid Augmentation of Citalopram Treatment for Patients With Major Depressive Disorder

(2011) Lev Gertsik et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis

(2011) M H Bloch et al.   MOLECULAR PSYCHIATRY

Updated systematic review and meta-analysis of the effects of n−3 long-chain polyunsaturated fatty acids on depressed mood

(2010) Katherine M Appleton et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

A psychoneuroimmunological review on cytokines involved in antidepressant treatment response

(2010) Debbie G. A. Janssen et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Marine n-3 Polyunsaturated Fatty Acids in Patients With End-stage Renal Failure and in Subjects Without Kidney Disease: A Comparative Study

(2010) Trine Madsen et al.   JOURNAL OF RENAL NUTRITION

Sertraline treatment is associated with an improvement in depression and health-related quality of life in chronic peritoneal dialysis patients

(2009) Huseyin Atalay et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

A Double-Blind, Randomized Controlled Trial of Ethyl-Eicosapentaenoate for Major Depressive Disorder

(2009) David Mischoulon et al.   JOURNAL OF CLINICAL PSYCHIATRY

Effect of Intradialytic Intravenous Administration of ω-3 Fatty Acids on Nutritional Status and Inflammatory Response in Hemodialysis Patients: A Pilot Study

(2009) Magdalena Szklarek-Kubicka et al.   JOURNAL OF RENAL NUTRITION

Fish Oil Supplementation Lowers C-Reactive Protein Levels Independent of Triglyceride Reduction in Patients With End-Stage Renal Disease

(2009) Rodney G. Bowden et al.   NUTRITION IN CLINICAL PRACTICE

Depression in End-Stage Renal Disease: Current Advances and Research

(2009) Joseph Chilcot et al.   SEMINARS IN DIALYSIS

Comparison of Therapeutic Effects of Omega-3 Fatty Acid Eicosapentaenoic Acid and Fluoxetine, Separately and in Combination, in Major Depressive Disorder

(2008) Shima Jazayeri et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Investigating the inflammatory phenotype of major depression: Focus on cytokines and polyunsaturated fatty acids

(2008) Timothy Dinan et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Depressive Symptoms and Proinflammatory Cytokine Levels in Chronic Renal Failure Patients

(2008) Erkan Dervisoglu et al.   NEPHRON CLINICAL PRACTICE

PSYCHOSOCIAL FACTORS IN PATIENTS WITH CHRONIC KIDNEY DISEASE: Depression and Renal Disease

(2005) Eliana Tossani et al.   SEMINARS IN DIALYSIS